Top

Cancer Causes & Control

Published in:

01-07-2009 | Original Paper

Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study

Authors: Heather A. Lankes, Angela J. Fought, Andrew M. Evens, Dennis D. Weisenburger, Brian C.-H. Chiu

Published in: Cancer Causes & Control | Issue 5/2009

Abstract

Objective

As factors that alter the immune system have been implicated in non-Hodgkin lymphoma (NHL) etiology, it is of interest to explore the association between vaccination and risk of NHL. Results of few epidemiologic studies conducted thus far are inconsistent, and only one has examined the association by histologic subtype.

Subjects

A population-based, case–control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002.

Methods

Information on vaccination for tetanus, polio, influenza, smallpox, and tuberculosis, as well as important environmental factors, was collected by telephone interview. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounders.

Results

We found that NHL risk was inversely associated with ever receiving a polio (OR = 0.59, CI = 0.40–0.87) or smallpox (OR = 0.71, CI = 0.51–0.98) vaccination, and positively associated with influenza vaccination (OR = 1.53, CI = 1.14–2.06). No significant association was found for tetanus or tuberculosis vaccination. The patterns of association were similar between men and women. Analysis by histologic subtypes showed that polio vaccination was associated with a lower risk of follicular (OR = 0.54, CI = 0.31–0.92) and chronic lymphocytic leukemia/small lymphocytic lymphomas (OR = 0.29, CI = 0.12–0.69) and smallpox vaccination was associated with a lower risk of marginal zone lymphoma (OR = 0.41, CI = 0.19–0.88). In contrast, ever receiving an influenza vaccination was associated with a higher risk of follicular (OR = 1.98, CI = 1.23–3.18) and diffuse large B cell lymphomas (OR = 1.88, CI = 1.13–3.12).

Conclusion

Risk of NHL is inversely associated with polio and smallpox vaccination and positively associated with influenza vaccination. These associations appear to differ by histologic subtype.

Grulich AE, Vajdic CM, Cozen W (2007) Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:405–408. doi:10.1158/1055-9965.EPI-06-1070 PubMedCrossRef

Filipovich AH, Mathur A, Kamat D, Shapiro RS (1992) Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52:5465–5467

Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20:1645–1654. doi:10.1097/01.aids.0000238411.75324.59 PubMedCrossRef

Goedert JJ (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27:390–401PubMed

Fisher SG, Fisher RI (2006) The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 18:417–424. doi:10.1097/01.cco.0000239878.31463.0b PubMedCrossRef

Ekstrom-Smedby K (2006) Epidemiology and etiology of non-Hodgkin lymphoma—a review. Acta Oncol 45:258–271. doi:10.1080/02841860500531682 PubMedCrossRef

Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344. doi:10.1001/archinte.165.20.2337 PubMedCrossRef

Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:401–404. doi:10.1158/1055-9965.EPI-06-1056 PubMedCrossRef

Jaffe ES (2004) Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst 96:571–573PubMedCrossRef

10.

Pozzato G, Mazzaro C, Crovatto M et al (1994) Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 84:3047–3053PubMed

11.

Suarez F, Lortholary O, Hermine O, Lecuit M (2006) Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107:3034–3044. doi:10.1182/blood-2005-09-3679 PubMedCrossRef

12.

Bernstein L, Ross RK (1992) Prior medication use and health history as risk factors for non-Hodgkin’s lymphoma: preliminary results from a case–control study in Los Angeles County. Cancer Res 52:5510–5515

13.

Holly EA, Bracci PM (2003) Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 158:316–327. doi:10.1093/aje/kwg145 PubMedCrossRef

14.

Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A (2000) Medical history and risk of Hodgkin’s and non-Hodgkin’s lymphomas. Eur J Cancer Prev 9:59–64. doi:10.1097/00008469-200002000-00008 PubMedCrossRef

15.

Chiu BC, Weisenburger DD (2003) An update of the epidemiology of non-Hodgkin’s lymphoma. Clin Lymphoma 4:161–168. doi:10.3816/CLM.2003.n.025 PubMedCrossRef

16.

Chiu BC, Kolar C, Gapstur SM, Lawson T, Anderson JR, Weisenburger DD (2005) Association of NAT and GST polymorphisms with non-Hodgkin’s lymphoma: a population-based case–control study. Br J Haematol 128:610–615. doi:10.1111/j.1365-2141.2004.05358.x PubMedCrossRef

17.

Chiu BC, Soni L, Gapstur SM, Fought AJ, Evens AM, Weisenburger DD (2007) Obesity and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 18:677–685. doi:10.1007/s10552-007-9013-9 PubMedCrossRef

18.

Waksberg J (1978) Sampling methods for random digit dialing. J Am Stat Assoc 73:40–46. doi:10.2307/2286513 CrossRef

19.

Breslow NE, Day NE (1993) Statistical methods in cancer research, vol 1. The analysis of case–control studies, IARC Sci Pub

20.

Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World health organization classification of tumors. pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon

21.

Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936PubMed

22.

Becker N, Deeg E, Rudiger T, Nieters A (2005) Medical history and risk for lymphoma: results of a population-based case–control study in Germany. Eur J Cancer 41:133–142. doi:10.1016/j.ejca.2004.08.028 PubMedCrossRef

23.

Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case–control study of non-Hodgkin’s lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375–389PubMed

24.

Cozen W, Cerhan JR, Martinez-Maza O et al (2007) The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control 18:821–831. doi:10.1007/s10552-007-9025-5 PubMedCrossRef

25.

Gergely L, Aleksza M, Varoczy L et al (2004) Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin’s lymphoma patients. Eur J Haematol 72:336–341. doi:10.1111/j.1600-0609.2004.00234.x PubMedCrossRef

26.

Haynes L, Swain SL (2006) Why aging T cells fail: implications for vaccination. Immunity 24:663–666. doi:10.1016/j.immuni.2006.06.003 PubMedCrossRef

27.

McKee AS, Munks MW, Marrack P (2007) How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27:687–690. doi:10.1016/j.immuni.2007.11.003 PubMedCrossRef

28.

Esser MT, Marchese RD, Kierstead LS et al (2003) Memory T cells and vaccines. Vaccine 21:419–430. doi:10.1016/S0264-410X(02)00407-3 PubMedCrossRef

29.

Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296:490–494. doi:10.1126/science.296.5567.490 PubMedCrossRef

30.

Mac Donald R, Baken L, Nelson A, Nichol KL (1999) Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16:173–177. doi:10.1016/S0749-3797(98)00159-7 PubMedCrossRef

31.

Shenson D, Dimartino D, Bolen J, Campbell M, Lu PJ, Singleton JA (2005) Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine 23:1015–1020. doi:10.1016/j.vaccine.2004.07.039 PubMedCrossRef

32.

Skull SA, Andrews RM, Byrnes GB et al (2007) Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 25:4775–4783. doi:10.1016/j.vaccine.2007.04.015 PubMedCrossRef

Title: Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study
Authors: Heather A. Lankes
Angela J. Fought
Andrew M. Evens
Dennis D. Weisenburger
Brian C.-H. Chiu
Publication date: 01-07-2009
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 5/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-008-9259-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objective

Subjects

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2009

Antioxidant vitamins and the risk of endometrial cancer: a dose–response meta-analysis

Physical activity and function in older, long-term colorectal cancer survivors

Prospective study of physical activity and the risk of ovarian cancer

Vitamin and mineral use and risk of prostate cancer: the case–control surveillance study

Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II)

Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer